Other
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
Thermo Fisher Scientific Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance increased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 100.0%, from -$28.00M to $0.00.
Analysis
StatementCash Flow Statement
SectionOther
CategoryProfitability
SignalContext dependent
VolatilityModerate
First reportedQ1 2021
Last reportedQ1 2026May 1, 2026
How to read this metric
A reduction in the valuation allowance increases net income, while an increase reduces it.
Detailed definition
Tracks the impact of adjustments to the valuation allowance for deferred tax assets on the effective tax rate. A valuati...
Peer comparison
Commonly used by companies with significant carryforward tax attributes.
Metric ID:
other_income_tax_reconciliation_change_in_deferred_tax_a_acfd4fHistorical Data
11 periods
| Q2 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $30.00M | -$87.00M | -$88.00M | $415.00M | $67.00M | -$183.00M | $47.00M | -$183.00M | -$94.00M | -$28.00M | $0.00 |
| QoQ Change | — | -390.0% | -1.1% | +571.6% | -83.9% | -373.1% | +125.7% | -489.4% | +48.6% | +70.2% | +100.0% |
| YoY Change | — | — | -393.3% | — | +177.0% | -144.1% | -29.9% | — | +48.6% | -159.6% | +100.0% |
Range-$183.00M – $415.00M
CAGR-100.0%
Avg YoY Growth-57.3%
Median YoY Growth-29.9%
Current Streak3 quarters growth
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's income tax reconciliation change in deferred tax assets valuation allowance?
- Thermo Fisher Scientific (TMO) reported income tax reconciliation change in deferred tax assets valuation allowance of $0.00 in Q1 2026.
- How has Thermo Fisher Scientific's income tax reconciliation change in deferred tax assets valuation allowance changed year-over-year?
- Thermo Fisher Scientific's income tax reconciliation change in deferred tax assets valuation allowance increased by 100.0% year-over-year, from -$28.00M to $0.00.
- What does income tax reconciliation change in deferred tax assets valuation allowance mean?
- The tax impact of changes in the estimated realizability of deferred tax assets.